youtube_live
Q3 2026 earnings • released • EPS beat +82.14% • Revenue beat +102.93%
See resultschevron_right
XLO:NASDAQ
Xilio Therapeutics Inc
$8.08
arrow_downward
-2.00%(-0.16) 1D
Nov 13, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for XLO...
Open
$7.96
High
$8.08
Low
$7.60
Mkt. cap
57.04M
Avg. vol.
13.73K
Volume
7.58K
52-wk high
$11.30
52-wk low
$6.47
EPS
-$1.54
Beta
-0.11
Shares outstanding
7.06M
No. of employees
76
Open
$7.96
High
$8.08
Low
$7.60
Mkt. cap
57.04M
Avg. vol.
13.73K
Volume
7.58K
52-wk high
$11.30
52-wk low
$6.47
EPS
-$1.54
Beta
-0.11
Shares outstanding
7.06M
No. of employees
76
News stories
From web sources and news partners
24/7 Wall St.
·
18 minutes ago
Union Pacific Beat the S&P 500 by 28.76 Points in the Past Year, and $1,000 From a Decade Ago Is Now Worth $3,693
Bloomberg.com
·
4 hours ago
SpaceX’s S&P 500 Bid Gets New Life as Musk Pitches Tesla Merger
The Motley Fool
·
2 hours ago
The S&P 500 Has Gone 18 Months Without a 10% Drop. Here's How the Next Year Has Gone After Streaks This Long.
Traders Union
·
2 hours ago
Tom McClellan: NYSE Composite Index better comparison for A-D Line than S&P 500
About Xilio Therapeutics Inc
CEO-
Employees76
Founded2016
HeadquartersWaltham, Massachusetts, United States
SectorHealth Care
IndustryBiotechnology
Websitexiliotx.com